Pharmabiz

Kindeva announces leadership transition to drive strategic growth

Kindeva announces leadership transition to drive strategic growth: Woodbury, Minnesota Saturday, January 17, 2026, 18:00 Hrs [IST] Kindeva, a global contract development and manuf ...
Pharmabiz

BD receives US FDA 510(k) clearance for EnCor EnCompass Breast Biopsy and Tissue Removal System

Franklin Lakes, New Jersey Saturday, January 17, 2026, 10:00 Hrs [IST] ...
Pharmabiz

DCOIWA sets bold three-year roadmap at first executive committee meeting of 2025-28 term

DCOIWA sets bold three-year roadmap at first executive committee meeting of 2025-28 term: Peethambaran Kunnathoor, Chennai ...
Pharmabiz

Alto Neuroscience receives US patent for ALTO-207; strengthens IP portfolio for patients with treatment-resistant depression

Alto Neuroscience receives US patent for ALTO-207; strengthens IP portfolio for patients with treatment-resistant depression: Mountain View, California Saturday, January 17, 2026, ...
Pharmabiz

Avalon Healthcare Solutions announces strategic investment to accelerate the future of diagnostic intelligence

Avalon Healthcare Solutions announces strategic investment to accelerate the future of diagnostic intelligence: Tampa, Florida Saturday, January 17, 2026, 16:00 Hrs [IST] Avalon H ...
Pharmabiz

Symeres appoints Jurgen Berendsen as chief financial officer to strengthen next phase of growth

Symeres appoints Jurgen Berendsen as chief financial officer to strengthen next phase of growth: Nijmegen, Netherlands Saturday, January 17, 2026, 15:00 Hrs [IST] Symeres, a leadi ...
Pharmabiz

Integrated DNA Technologies collaborates with Ansa Biotechnologies to expand capabilities to IDT’s synthetic biology portfolio

Integrated DNA Technologies collaborates with Ansa Biotechnologies to expand capabilities to IDT’s synthetic biology portfolio: Sunnyvale Saturday, January 17, 2026, 14:00 Hrs [ ...
Pharmabiz

UK MHRA approves up to 7.2mg dose of semaglutide for patients with obesity only

UK MHRA approves up to 7.2mg dose of semaglutide for patients with obesity only: United Kingdom Saturday, January 17, 2026, 13:00 Hrs [IST] The UK Medicines and Healthcare product ...
Pharmabiz

China NMPA approves Sanofi’s Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome

China NMPA approves Sanofi’s Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome: Paris Saturday, January 17, 2026, 11:00 Hrs ...
Pharmabiz

Zylox-Tonbridge to acquire Germany-based medical technology company, Optimed to accelerate expansion in the global medtech market

Zylox-Tonbridge to acquire Germany-based medical technology company, Optimed to accelerate expansion in the global medtech market: Hangzhou, China Saturday, January 17, 2026, 09:0 ...
Opinion
PharmabizOpinion

Govt must make budgetary provision for inclusion of Ayurveda in AB-PMJAY: Rajiv Vasudevan

Govt must make budgetary provision for inclusion of Ayurveda in AB-PMJAY: Rajiv Vasudevan: Shardul Nautiyal, Mumbai Saturday, January 17, 2026, 08:00 Hrs [IST] The Government of I ...
Pharmabiz

BMS Foundation launches national programme to bolster mental health diversion initiatives

BMS Foundation launches national programme to bolster mental health diversion initiatives: Lawrenceville, New Jersey Saturday, January 17, 2026, 12:00 Hrs [IST] The Bristol Myers ...